Abstract:Background: Achieving a clear resection margins for low rectal cancer is technically challenging. Transanal approach to total mesorectal excision (TME) was introduced in order to address the challenges associated with the laparoscopic approach in treating low rectal cancers. However, previous meta-analyses have included mixed population with mid and low rectal tumours when comparing both approaches which has made the interpretation of the real differences between two approaches in treating low rectal cancer difficult. Aim: To investigate the outcomes of transanal TME (TaTME) and laparoscopic TME (LaTME) in patients with low rectal cancer. Methods: A comprehensive systematic review of comparative studies was performed in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. Intraoperative and postoperative complications, anastomotic leak, R0 resection, completeness of mesorectal excision, circumferential resection margin (CRM), distal resection margin (DRM), harvested lymph nodes, and operation time were the investigated outcome measures. Results: We included twelve comparative studies enrolling 969 patients comparing TaTME (n = 969) and LaTME (n = 476) in patients with low rectal tumours. TaTME was associated with significantly lower risk of postoperative complications (OR: 0.74, P = 0.04), anastomotic leak (OR: 0.59, P = 0.02), and conversion to an open procedure (OR: 0.29, P = 0.002) in comparison with LaTME. Moreover, the rate of R0 resection was significantly higher in the TaTME group (OR: 1.96, P = 0.03). Nevertheless, TaTME and LaTME were comparable in terms of rate of intraoperative complications (OR: 1.87; P = 0.23), completeness of mesoractal excision (OR: 1.57, P = 0.15), harvested lymph nodes (MD: -0.05, P = 0.96), DRM (MD: -0.94; P = 0.17), CRM (MD: 1.08, P = 0.17), positive CRM (OR: 0.64, P = 0.11) and procedure time (MD: -6.99 min, P = 0.45). Conclusion: Our findings indicated that for low rectal tumours, TaTME is associated with better clinical and short term oncological outcomes compared to LaTME. More randomised controlled trials are required to confirm these findings and to evaluate long term oncological and functional outcomes.

Transanal total mesorectal excision for low and middle rectal cancer: time for audit?

The application of laparoscopic total mesorectal excision with preservation of anal sphincter for rectal cancer

Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients

Transanal total mesorectal excision (taTME) for cancer located in the lower rectum: short- and mid-term results

A Way to Start Transanal Total Mesorectal Excision for Rectal Cancer

The role of transanal total mesorectal excision in the treatment of rectal cancer: a systematic review

Transanal Total Mesorectal Excision for Rectal Cancer: a Multicentric Cohort Study.

Laparoscopic total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer: A systematic review and meta-analysis

Oncological monitoring after transanal total mesorectal excision (TaTME) for rectal neoplasia

Transanal total mesorectal excision: Understanding indications, managing complications, and effective prevention methods

Evolution of transanal total mesorectal excision for rectal cancer: From top to bottom

Transanal total mesorectal excision for rectal cancer: hype or new hope?

Meta-analysis of transanal vs laparoscopic total mesorectal excision of low rectal cancer: Importance of appropriate patient selection

Clinical Status and Future Prospects of Transanal Total Mesorectal Excision

Transanal total mesorectal excision: short- and long-term results of four certified colorectal cancer centers in Germany

Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer

Evaluation of Short-Term Outcomes of Laparoscopic and Open Total Mesorectal Excision for Mid and Distal Rectal Cancer

[Perceptions of transanal total mesorectal excision surgical quality and patient screening]

Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial

Laparoscopic-assisted Transanal Total Mesorectal Excision for Middle-Low Rectal Carcinoma: A Clinical Study of 19 Cases.

A systematic review and meta‐analysis of oncological outcomes with transanal total mesorectal excision for rectal cancer